Ruchi Bansal

[Ruchi Bansal @RuchiBansalUT]

🚨 ECLCB-9 is now officially endorsed by @EASLnews!
📅 Registration closes 31 July 2025
🪑 Limited to 125 spots!
🔗 https://t.co/j15T9UT1C8
#ECLCB9 #LiverResearch #EASL

[Ruchi Bansal @RuchiBansalUT]

📣 Don’t miss #ECLCB9, 2025.
📍 Groningen | 📅 24–26 Sept 2025
📝 Register by 31 July 2025 → https://t.co/j15T9UStMA
#ECLCB9 #LiverCancer #BasicHepatology #TranslationalHepatology

[Ruchi Bansal @RuchiBansalUT]

ONLY FEW DAYS LEFT TO SUBMIT YOUR ABSTRACT TO ECLCB-9.
Submit your abstract by 15 June 2025 and Register by 15 July 2025! For more information, check our website https://t.co/Hfc4iVtzon.

[Ruchi Bansal @RuchiBansalUT]

Extended Deadline!
Submit your abstract by 15 June 2025 and Register by 15 July 2025! For more information, check our website https://t.co/j15T9UStMA.

[Ruchi Bansal @RuchiBansalUT]

Call for Abstracts & Registration Now Open! 🚨

European Club for Liver Cell Biology-9 (ECLCB-9) is now officially open for abstract submission and registration! Submit your abstract and register here https://t.co/j15T9UStMA

[EASLnews @EASLnews]

🌐Fatty liver disease affects 1 in 3 adults & 10% of children. Join the call for action to combat this growing public health threat.🎤Attend the EASL Studio special episode “Promoting Liver Health: an urgent call for action at WHO ", May 22 19:30-20:00h. https://t.co/H2Aj1g8pkG

[Journal of Hepatology @JHepatology]

📢Dietary supplementation with #VitaminB12 & #folate could have therapeutic potential for the prevention/treatment of #NonAlcoholicSteatohepatitis

➡️Based on studies in mice, primates & humans

🔓#OpenAccess at👉https://t.co/1YbdFXTr4Y

#LiverTwitter

[Ramon Bataller @rabataller]

I am amazed by the role of GUT BACTERIA:

🔸Many years ago we showed that smoking exacerbates fatty liver disease.
🔸This study in @Nature shows that gut bacteria DEGRADES NICOTINE and prevents the effects of smoking in the liver.

https://t.co/Ll8QiZ1mLA #livertwitter

[Daniel Huang @DrHuangDQ]

HCC incidence in alcohol-cirrhosis

5-year HCC risk= 3%
10-year HCC risk= 9%,
⬆️incidence in cohorts with surveillance

from @DrLoomba lab
@DarrenTanJH @ChengHanNg @DrMaralMD #GITwitter #LiverCancerSIG

Free (temporary) link to article in @AGA_CGH
👇
https://t.co/2IHfY7vq5i

[Ramon Bataller @rabataller]

Do you want to know about novel HUMAN-BASED experimental tools to do liver research ?
🔸Liver-derived organoids
🔸Liver-on-a-chip

Read these two excellent reviews.

https://t.co/TGeqDjyE4E
https://t.co/ozOYDHKy4u
#livertwitter

[Ramon Bataller @rabataller]

Did you know that LIVER CANCER is one of the 3 top causes of cancer-related death in 46 countries ?

And its incidence is rapidly growing due to fatty liver disease.

#LiverCancerAwarenessMonth #livertwitter @JHepatology
https://t.co/Ee2SztDC11

[Ramon Bataller @rabataller]

I use lot of SWEETENER instead of sugar in my daily coffees. I always wondered if they are safe.

This clinical trial in @CellPressNews in humans shows that sweeteners:
🔸Change your microbiome.
🔸Alter your glycemic response.

#livertwitter #medtwitter https://t.co/VP2KVDchqv

[ESBRA SOCIETY @esbra_society]

https://t.co/j5O762zewh

[ElePalma @DrElePalma]

A read for the weekend! 🗞 👉🏼know more about ESBRA community and the new Early-career investigators committee! @DrAntonioRiva @MohsenSubhani @JeromeJeanblanc @karkkainen_olli @EsiDomi @EstelledBarbier @RuchiBa91629035

[Ramon Bataller @rabataller]

In this study by Bin Gao, we show that there are two PHENOTYPES in alcoholic hepatitis based on liver immune cells:
🔸HIGH neutrophils: more steatosis, less fibrosis
🔸LOW neutrophils: less steatosis, cirrhosis

@NIAAAnews @jclinicalinvest
https://t.co/UYUGz4HCdU #livertwitter

[ESBRA SOCIETY @esbra_society]

Meet @ruchibansal she has joined ESBRA ECI committee
Ruschi works at University of Twente, Netherlands, where she leads translational liver research group.

It is a strength to have you on board Ruschi.

[Ramon Bataller @rabataller]

Is it safe for the liver to drink heavily the WEEKEND and be sober during the rest of the week?

Probably YES. But if you have METABOLIC SYNDROME, definitively NO.

We explain it in this editorial with @CotsVentura

https://t.co/eAQitLANny #livertwitter

[Ramon Bataller @rabataller]

This paper will be transformational: 25% of patients with presumed NAFLD were drinking ALCOHOL excessively. Some patients admitted it, but many others underreported it.

“THE DIAGNOSIS OF NAFLD SHOULD REQUIRE NEGATIVE ALCOHOL METABOLITES”.

https://t.co/6XmElXhAaj
#LiverTwitter

[Ramon Bataller @rabataller]

Is INTERMITTENT FASTING better for weight loss in obese patients? This recent NEJM paper from China shows:
🔸It is no more effective than the standard hypocaloric diet.
🔸 It does not offer an additional advantage on metabolic risk factors.
https://t.co/Lnc4qTbkJQ
#livertwitter

[Ruchi Bansal @RuchiBansalUT]

@YoungAcademyUT It was a great pleasure to be the YA@UT board member and work with the great YA@UT members team. A warm welcome to new YA@UT members and Albert. Looking forward to following the YA@UT in the coming years and contributing to it as a YA@UT alumnus.